mafosfamide has been researched along with Ache in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czech, T; Dieckmann, K; Dietrich, W; Falger, J; Günes, M; Hainfellner, J; Pillwein, K; Prayer, D; Rössler, K; Schuller, E; Slavc, I | 1 |
Blaney, SM; Boyett, J; Friedman, H; Gajjar, A; Geyer, R; Heideman, R; Horowtiz, M; Hunt, D; Kieran, M; Kun, L; Packer, R; Phillips, P; Pollack, IF; Prados, M | 1 |
Hilgard, P; Pohl, J | 1 |
2 trial(s) available for mafosfamide and Ache
Article | Year |
---|---|
Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Headache; Humans; Injections, Intraventricular; Injections, Spinal; Male; Meningeal Neoplasms; Nausea; Pain; Treatment Outcome | 2003 |
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
Topics: Affect; Age Factors; Analgesics, Opioid; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cyclophosphamide; Dexamethasone; Female; Glucocorticoids; Headache; Humans; Infant; Injections, Spinal; Male; Maximum Tolerated Dose; Morphine; Neoplasms, Germ Cell and Embryonal; Pain | 2005 |
1 other study(ies) available for mafosfamide and Ache
Article | Year |
---|---|
Cause and prevention of mafosfamide-induced venous pain.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Cyclophosphamide; Mesna; Pain; Rats; Veins | 1986 |